BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Allergy to pollen
,
Heart
,
Anticancer prodrugs
,
Clofibrate
,
rs2476601
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ADAM12
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor …
Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in…
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladd…
ADAM12 is an independent predictor of poor prognosis in liver cancer.
ADAM12 as a Clinical Prognostic Indicator Associated with Tumor Immune Infiltration in Lung Adenocar…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Thera…
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
Identification of miRNAs Associated With Gender Difference in Osteoarthritis Patients
Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ